Promega builds plant to produce regulated products

Published: 29-Aug-2011
Manufacturing Analysis

Including sample preparation systems and reagents

Promega Corporation, based in Madison, Wisconsin, US, has held a ground-breaking ceremony for a new cGMP facility to support business growth and customers who need FDA-regulated molecular biology products. These include sample preparation systems and reagents, which are part of diagnostic and medical tests sold by human diagnostic test providers.

The 260,000ft2 (24,150m2) facility will require an additional 100 people in the next five years. Most of the building will be dedicated to fixed and flexible manufacturing areas. It will also house a customer experience centre for training, laboratory demonstrations and conferences.

‘This building is our next step in expanding our product supply capabilities worldwide,’ said ceo Bill Linton.

Plans include a number of sustainable practices, including geothermal heating and cooling, dark sky compliant lighting, prairie restoration, bio-retention ponds for storm water run off among other sustainable features and construction practices.

Promega Corporation provides solutions and technical support to the life sciences industry. Its 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification.

See more

You may also like

Ingredients

Promega unveils cellular target engagement technology

Read more
TarSeer BRETSA platform enables early-stage studies for difficult proteins in drug discovery

Trending Articles

  1. Thermo Fisher and SHL Medical collaborate to integrate autoinjector assembly with sterile fill-finish at Ridgefield site The duo will integrate the SHL's Molly autoinjector platform into Thermo's Ridgefield, New Jersey facility, creating an end-to-end US-based solution for drug-device combination products spanning sterile manufacturing, device assembly and commercial packaging
  2. Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Semaglutide patent cliff: pharma industry braces for impact With the weight-loss industry shifting from a monopoly held by innovators to a high-volume, competitive generic market, the pharma manufacturing sector is gearing up for a "generic wave" with investments into large-scale protein synthesis and facilities for injectables
  4. New ion chromatograph enhances water quality testing efficiency Shimadzu’s Nexera IC combines automation and intuitive software to support reliable ion analysis and reduce laboratory workload
  5. AQUARIA - enhancing drying performance while reducing consumption AQUARIA stands out within the diverse range of parts washers for the pharmaceutical industry that have been developed by IMA over the last two decades. Designed to ensure maximum performance in cleaning and validation with high efficiency, AQUARIA is renowned for its reduced consumption of energy, water, detergents and compressed air. These qualities match the pharmaceutical industry’s current attention to environmental issues and prove how IMA is actively supporting sustainability across a wide spectrum of processes, where its solutions represent a respected benchmark

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

You may also like

Ingredients

Promega unveils cellular target engagement technology

TarSeer BRETSA platform enables early-stage studies for difficult proteins in drug discovery
Manufacturing

Promega opens new Shanghai facility

Provides additional r&d and cGMP manufacturing capabilities
Analysis

Shimadzu celebrates a 70th anniversary

Gas chromatography (GC) product line celebrates 70th anniversary, European and world premieres underscore progress in laboratory analytics
Manufacturing

Romaco Holding appoint Chief Sales Officer

Nicola Magriotis will be responsible for the sales and service organisation of the international Romaco Group
Manufacturing

Degasser for volatile and aggressive solvents

Biotech Fluidics announce the DEGASi Integration HFIP - a high-performance online system designed to efficiently degas even the toughest solvents. This unique degasser is fully compatible with a wide range of volatile and aggressive liquids including Hexafluoroisopropanol (HFIP) and silanes but can also manage all other solvents used for GPC/SEC and HPLC
Manufacturing

Bracco upgrades GMP manufacturing facility for cell therapy product

Facility upgrades will support clinical-grade manufacturing of Bracco's microbubble-based cell selection and activation technology, with GMP readiness expected mid-2027
Manufacturing

Samsung Biologics completes acquisition of GSK facility in Maryland

Samsung Biologics has completed its acquisition of a manufacturing facility from GSK in Rockville, Maryland, adding 60,000 litres of drug substance capacity to its global capacity and establishing its first manufacturing presence in the US
Subscribe now